Med. praxi 2013; 10(8-9): 286-290

Allergic rhinitis and allergic bronchial asthma

MUDr.Irena Krčmová, CSc., MUDr.Jakub Novosad, Ph.D.
Ústav klinické imunologie a alergologie, Fakultní nemocnice, Hradec Králové

Although allergic diseases present with clinical organ manifestations, allergy is now recognized as a systemic condition. Allergic disease

develops due to numerous environmental factors in a genetically predisposed individual. The most common allergic diseases are atopic

dermatitis, allergic rhinitis, and bronchial asthma. The above-mentioned allergy types frequently combine with one another. Atopic

dermatitis and allergic rhinitis are referred to as pre-asthmatic conditions. Eosinophilic rhinitis spreads distally and patients with allergic

rhinitis have a 3–4-fold higher risk of developing asthma. For an allergic person it is important to know that an allergic disease that has

already occurred is not completely curable, but is well treatable.

Keywords: allergic rhinitis, bronchial asthma, asthmatic equivalent

Published: September 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krčmová I, Novosad J. Allergic rhinitis and allergic bronchial asthma. Med. praxi. 2013;10(8-9):286-290.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Alkis T. Rhinitis and asthma: Evidence for respiratory systém integration. J Allergy Clin Immunol 2003; 6: 1171-117 9. Go to original source... Go to PubMed...
    2. Bel EH. Clinical phenotypes of asthma. Curr Opin Pulm Med 2004; 10: 44-50. Go to original source... Go to PubMed...
    3. Bousquet J, et al. ARIA 2008 update. Allergy 2008; 63(Supl. 86): 8-160. Go to original source... Go to PubMed...
    4. Bousquet J, et al. Development and immplementation of guidelines in allergic rhinitis - an ARIA-GA2LEN paper. Allergy 2010; 65: 1212-1221. Go to original source... Go to PubMed...
    5. Boušová K, Krčmová I. Profesionální astma a alergická rýma v ordinaci praktického lékaře. Med. praxi 2010; 7(10): 376-379.
    6. Braunstahl G-J, Fokkens WJ. Nasal involvement in allergic astma. Allergy 2003; 58: 1235-1243. Go to original source... Go to PubMed...
    7. Corren J. The link between allergic rhinitis and asthma, otitis media, sinusitis, and nasal polyps. Rhinitis 2000; 2: 445-460. Go to original source...
    8. Čáp P. Význam stanovení vydechovaného oxidu dusnatého u astmatu. Alergie 2005; 7: 2 91-2 95.
    9. Diagnostika, léčba a prevence průduškového astmatu v České republice. Uvedení globální strategie do praxe. ČIPA, Jalna 2008: 120.
    10. Fišerová J, Chlumský J, Satinská J, a kol. Funkční vyšetření plic. GEUM 2005: 128.
    11. Global Initiative for Asthma (GINA) Workshop Report - Revised 2011; www.ginasthma.org.
    12. Holgate S, Bisgaard H, Bjermer L, et al. The Brussels Declaration: the need for change in asthma management. Eur Respir J 2008; 32: 1433-1442. Go to original source... Go to PubMed...
    13. Illi S, et al. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet, 2006; 368(9537): 763-770. Go to original source... Go to PubMed...
    14. Kašák V. Klinický význam konceptu tíže a kontroly astmatu. Farmakoterapie 200 9; 5: 47-53.
    15. Krčmová I, Novosad J. Bronchiální astma - praktické aspekty. Interní Med. 2010; 12(4): 196-199.
    16. Krčmová I, Alergická rýma - klinické aspekty a její léčba. Klin Farmakol Farm 2011; 25(4): 177-183.
    17. Krčmová I. Nazální kortikosteroidy a ovlivnění očních příznaků alergické rinitidy. Remedia 2009; 19, 1: 22-28.
    18. Lange B, Lukat KF, Rettig K, et al. Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis. Annals Allergy Asthma Immunol. 2005; 95(3): 272-282. Go to original source... Go to PubMed...
    19. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 5 9: 46 9-478. Go to original source... Go to PubMed...
    20. Moshammer H, Neuberger M. Smoking in pregnancy. Environ Health Perspect, 2006; 114(3): p. A150. Go to original source... Go to PubMed...
    21. Novotná B. Žena a astma. Alergie 2009; 11: 281-284. Go to original source...
    22. Panzner P. Oralair - sublingvální tablety pro specifickou imunoterapii alergie způsobené pyly trav. Alergie 2010 (3); 207-212.
    23. Petrů V, Chrobok V, Klozar J. Alergická rýma: Zásady diagnostiky a léčby Mediforum, 2. přepracované vydání, 2010, nakladatelství Maxdorf s.r.o.
    24. Salajka F, Kašák V, Krčmová I, Konštacký S. Asthma bronchiale. Doporučený diagnostický a léčebný postup pro všeobecné praktické lékaře. Centrum doporučených postupů pro praktické lékaře. Novelizace 2008.
    25. Seberová E. Alergická rýma. Maxdorf, Praha 2006: 112.
    26. Sedlák V, Chlumský J, Teřl M, a kol. Doporučený postup diagnostiky a léčby obtížně léčitelného bronchiálního astmatu NTCA 2009; dostupný na www.pneumologie.cz.
    27. Shin JW, et al. Atopy and house dust mite sensitization as risk factors for asthma in children. Yonsei Med J, 2005; 46(5): p. 629-634. Go to original source... Go to PubMed...
    28. Taylor DR, et al. A new perspective on concepts of asthma severity and control. Eur Respir J 2008; 32: 545-554. Go to original source... Go to PubMed...
    29. Teřl M. Pohled na astma prizmatem eozinofilie a alergie: návrh diagnostické klasifikace. Alergie 2009; 11(4): 247-255.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.